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HIF-1α is a key mediator of the lung
inflammatory potential of lithium-ion
battery particles
Violaine Sironval1* , Mihaly Palmai-Pallag1, Rita Vanbever2, François Huaux1, Jorge Mejia3, Stéphane Lucas3,
Dominique Lison1 and Sybille van den Brule1
Abstract
Background: Li-ion batteries (LIB) are increasingly used worldwide. They are made of low solubility micrometric
particles, implying a potential for inhalation toxicity in occupational settings and possibly for consumers. LiCoO2
(LCO), one of the most used cathode material, induces inflammatory and fibrotic lung responses in mice. LCO also
stabilizes hypoxia-inducible factor (HIF) -1α, a factor implicated in inflammation, fibrosis and carcinogenicity. Here,
we investigated the role of cobalt, nickel and HIF-1α as determinants of toxicity, and evaluated their predictive
value for the lung toxicity of LIB particles in in vitro assays.
Results: By testing a set of 5 selected LIB particles (LCO, LiNiMnCoO2, LiNiCoAlO2) with different cobalt and nickel
contents, we found a positive correlation between their in vivo lung inflammatory activity, and (i) Co and Ni particle
content and their bioaccessibility and (ii) the stabilization of HIF-1α in the lung. Inhibition of HIF-1α with chetomin
or PX-478 blunted the lung inflammatory response to LCO in mice. In IL-1β deficient mice, HIF-1α was the upstream
signal of the inflammatory lung response to LCO. In vitro, the level of HIF-1α stabilization induced by LIB particles in
BEAS-2B cells correlated with the intensity of lung inflammation induced by the same particles in vivo.
Conclusions: We conclude that HIF-1α, stabilized in lung cells by released Co and Ni ions, is a mechanism-based
biomarker of lung inflammatory responses induced by LIB particles containing Co/Ni. Documenting the Co/Ni
content of LIB particles, their bioaccessibility and their capacity to stabilize HIF-1α in vitro can be used to predict
the lung inflammatory potential of LIB particles.
Keywords: Predictive toxicology, IL-1β, Epithelial cells, Biomarker, Cobalt, Nickel
Background
Li-ion batteries (LIB) represent one of the best solutions
for various electric grid applications, to improve the
quality of energy harvested from wind, solar, geo-thermal
and other renewable sources [1]. LIB electrodes are made
of poorly water-soluble particles, micrometric in size, that
might thus be respirable and biopersistent in the human
respiratory tract. Exposure to LIB components is the most
worrying for workers producing and handling LIB parti-
cles but future applications of LIB, such as multi-layer sys-
tems made for spray-paintable or printable DIY batteries
[2–4], might extend the potential for inhalation exposure
to consumers.
We previously assessed the lung toxicity of three
commonly used LIB particles, lithium iron phosphate
(LiFePO4/LFP), lithium titanium oxide (Li4Ti5O12/LTO)
and lithium cobalt oxide (LiCoO2/LCO), and concluded
that they represent a respiratory hazard independently of
their Li content [5]. Acute inflammatory responses were
recorded with the three particles. Long-term inflammation
was maintained after LFP and LCO, and only LCO in-
duced fibrotic responses. Increased hypoxia-inducible fac-
tor (HIF)-1α was recorded in the lung of mice exposed to
LCO. HIF-1 is a heterodimeric transcriptional factor con-
sisting of two subunits, HIF-1α and HIF-1β, constitutively
expressed in all cells [6]. HIF-1α is the oxygen-sensitive
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subunit regulating the level of active HIF-1 [7]. Under
normoxia, HIF-1α is continuously degraded by ubiquitin-
and proteasome-dependent pathways. HIF-1α degradation
is mainly controlled by the hydroxylation of two specific
prolyl residues by prolyl hydroxylase. During hypoxia,
HIF-1α is stabilized, heterodimerizes with HIF-1β, recruits
coactivators, and induces the transcription of target genes
such as interleukin (IL)-6, vascular endothelial growth
factor (VEGF)-A, erythropoietin (EPO) and transforming
growth factor (TGF)-β [6]. Ions such as Co2+ or Ni2+
mimic hypoxia and stabilize HIF-1α by blocking the iron-
binding site of prolyl hydroxylase or directly binding to
HIF-1α, thus preventing its degradation [8–10].
A wide diversity of particles, containing metals such as
cobalt and/or nickel, are used in LIB electrodes [1, 11].
In view of the large variety of existing and future LIB
materials, their increasing production, use and disposal,
it appears essential to better identify their health hazards
and to generate information about mechanisms of tox-
icity. Here, we investigated the role of Co and Ni and
their capacity to stabilize HIF-1α in the lung responses
to LIB particles, and evaluated the value of in vitro as-
says to predict their potential for lung toxicity.
Results
Contrasting lung toxicity of LIB particles
We first documented the dose-responses for lung in-
flammatory and fibrotic responses induced by LCO.
Mice were exposed by oro-pharyngeal aspiration to LCO
(0.1, 0.5 or 2 mg). Crystalline silica particles were se-
lected as positive control. Two months after exposure,
no mortality was recorded at any of the doses tested. A
clear inflammatory cell accumulation was observed from
0.5 mg LCO and at 2 mg silica (Fig. 1a). LCO also in-
duced a stronger fibrotic response than silica (Fig. 1b, d).
LCO particles are thus more potent than crystalline
silica particles, despite their larger size distribution (7.21
vs > 50% fine particle fraction, respectively). HIF-1α was
strongly stabilized in lung cells by LCO in a dose-
dependent manner, only weakly by silica (Fig. 1c).
We next assessed the lung responses to other particles
used in LIB, with different compositions (Table 1) and
containing fine particles (Table 1 and Additional file 1:
Figure S1). LiNiMnCoO2 (NMC) and LiNiCoAlO2 (NCA)
also contain nickel. Co3O4 was used as a reference low
solubility cobalt particle [12].
Mice were first exposed to 1 or 2 mg LIB particles by
oro-pharyngeal aspiration. Surprisingly, mice died shortly
after exposure, except with Co3O4 (Fig. 2a). The dose was
then reduced to 0.5mg for the most active particles
(NMC6:2:2, NMC8:1:1, NCA and LCO). After 2m, all LIB
particles induced inflammation (cell infiltration) at the
dose of 2mg (Fig. 2b). Co3O4 induced a slight inflamma-
tion. Lung fibrotic manifestations (score ≥ 2) were induced
by LCO and NCA particles at 0.5 mg whereas, at 1 and 2
mg, LCO, NMC1:1:1 and NCA induced clear fibrotic
changes with fibrotic masses (Fig. 2c). NMC 6:2:2, 8:1:1
and Co3O4 induced some isolated fibrotic changes (See
Additional file 1: Figure S2). All particles induced different
(dose-dependent) levels of HIF-1α stabilization (Fig. 2d).
As these LIB particles induced acute toxicity (mortality)
and severe lung responses, it appeared crucial to identify
the mechanisms of this toxicity.
We first focused on the determinants of acute toxicity.
Because tested LIB particles contained Co and/or Ni, 2
elements able to induce pulmonary toxicity [13–15], we
assessed the bioaccessibility of these metals in artificial
fluids mimicking the extracellular (pH 7.3) and the pha-
golysosomal (pH 4.2) cellular compartments over a
period of 30 days (Fig. 3). The amount of Co released at
pH 7.3 was very low for all particles (Fig. 3 a) in com-
parison to pH 4.2 (Fig. 3b), suggesting that Co ions can
be released in the phagolysosomes. The pattern of Co
release at pH 4.2 was different for all LIB particles, LCO
releasing the largest amount of Co. Co3O4 particles re-
leased more Co than the other LIB particles. NCA and
NMC6:2:2 released a higher amount of Co than NNC1:
1:1 and NMC8:1:1. At pH 7.3, Ni bioaccessibility was
also very low (Fig. 3c). At pH 4.2, the Ni bioaccessibility
pattern was different for all LIB particles, NCA and
NMC8:1:1 releasing the highest amount of Ni (Fig. 3d).
Thus, the patterns of Co and Ni released from LIB parti-
cles did not follow their Co or Ni % content. We next
performed a bivariate analysis to identify the determi-
nants of acute toxicity (mortality) after exposure to LIB
particles. We analyzed the implication of the Co and Ni
amount contained in the administered doses (0.5, 1 or 2
mg LIB particles) and their bioaccessibility (calculated
from ion % released at pH 4.2) either separately or to-
gether (Table 2). The acute toxic potential (mortality) of
these LIB particles was related to the Ni content and its
release from the particles.
HIF-1α is a determinant of the lung inflammation induced
by LIB particles
We next performed similar analyses to identify the
determinants of the late inflammatory response (inflam-
matory cell infiltration in the broncho-alveolar lavage
(BAL) 2 months after administration) (Table 3), includ-
ing lung HIF-1α content, BAL fuid (BALF) lactate deshy-
drogenase (LDH) activity as a marker of cytotoxicity, Ni
and/or Co contents of LIB particles and their bioaccessi-
bility (calculated from the % released at pH 4.2). HIF-1α
stabilization in lung tissue, the sum of Co and Ni con-
tent in particles and their summed bioaccessibility sig-
nificantly correlated with lung inflammation (Table 3).
The sum of Ni and Co content and their bioaccessibility
also positively correlated with the stabilization of HIF-1α
Sironval et al. Particle and Fibre Toxicology           (2019) 16:35 Page 2 of 12
(r = 0.539, p-value = 0.0001 and r = 0.500, p-value = 0.0001
respectively). The same analysis did not show any signifi-
cant association of the same variables with fibrotic re-
sponses (data not shown). These results thus supported
the hypothesis that HIF-1α stabilization induced by Co
and Ni ions drives the lung inflammatory responses of
these LIB particles.
HIF-1α mediates lung inflammation induced by LCO
We next evaluated the implication of HIF-1α in the toxic
activity of LIB particles by inhibiting its activity with
chetomin, a disrupter of HIF binding to its transcriptional
co-activator P300 [16]. This was assessed with LCO, the
LIB particle inducing the strongest lung inflammation and
fibrotic responses, and crystalline silica particles as con-
trol. We previously observed that LCO early stabilized
HIF-1α in the lung 3 days after exposure and later after
2 months. Crystalline silica weakly stabilized HIF-1α
only 2 months after exposure (Fig. 1), suggesting that
late inflammatory of fibrotic responses might also contrib-
ute to HIF-1α stabilization [5]. Therefore, we first focused
on the implication of HIF-1α in early lung responses to
isolate the specific effect of LCO. Three days after admin-
istration of 0.5 or 2mg LCO, inflammatory cell recruit-
ment including neutrophils and the pro-inflammatory
cytokines IL-1β and IL-6 in BALF were largely reduced by
the inhibition of HIF-1α (Fig. 4a, b, c, d). This reduction
was not observed in silica-exposed mice. To further assess
Fig. 1 LCO induces stronger lung toxicity than silica particles. C57BL/6Jrj mice were treated with an oro-pharyngeal aspiration of NaCl (control),
0.1, 0.5 or 2 mg LCO or crystalline silica (Sil). Mice were euthanized after 2 months. Inflammatory cell infiltration (a) was measured in BAL; HIF-1α
(c) in lung homogenates. Severity of fibrotic responses was scored according to Hübner et al. (2008) on lung sections stained with Sirius red (b).
Lung sections stained with Sirius red (magnification 10x and 200x) (d). *P < 0.05, **P < 0.01 and ***P < 0.001 relative to NaCl-treated mice (one-way
ANOVA followed by a Dunnett’s multiple comparison, N = 1, n = 5, means ± SEM)
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inflammation, lung sections of mice exposed to 2mg
particles were stained with hematoxylin and eosin (HE).
Aggregates of lymphocytes and macrophages, and accu-
mulation of cellular debris were observed in LCO lungs to
a larger extent than in silica lungs (Fig. 4e). In LCO lungs
from mice treated with the inhibitor, inflammation was
drastically reduced. In silica lungs, the formation of in-
flammatory foci was not prevented by chetomin (Fig. 4e).
These results suggested that HIF-1α is specifically im-
plicated in early lung inflammation induced by LCO.
To confirm this observation, we used PX-478, another
inhibitor of HIF-1α responses targeting a different
pathway. PX-478 inhibits HIF-1α by decreasing its
translation and transcription, as well as de-ubiquitination
[17–19]. Similar results were observed with this inhibitor
(See Additional file 1: Figure S3), confirming the implica-
tion of HIF-1α in early lung inflammation induced by
LCO. Similar experiments were conducted over a period
of 1 and 2months to assess the potential implication of
HIF-1α in later lung responses to LCO, but mice did not
tolerate a longer treatment with chetomin or PX-478 (not
shown).
HIF-1α stabilization acts upstream of lung inflammation
We next investigated the possible influence of lung in-
flammation on HIF-1α stabilization. To minimize the
number of animals used, IL-1β knock-out (KO) mice were
treated only with 2mg of LCO or crystalline silica parti-
cles and compared to their wild-type (WT) counterparts
(C57BL/6JRj) after 3 days. Inflammatory cells, including
neutrophils, were recruited after LCO and crystalline silica
particles in WT mice. Only LCO induced HIF-1α
stabilization in WT mice. All inflammatory parameters in-
duced in WT mice were strongly reduced in IL-1β KO
mice after LCO and (although not significantly) after silica
(Fig. 5a, b, c). HIF-1α stabilization induced by LCO was,
however, not modified in IL-1β KO mice (Fig. 5d),
indicating that HIF-1α stabilization induced by LCO parti-
cles is not a consequence of inflammation.
In vitro HIF-1α stabilization predicts the lung
inflammatory potential of LIB particles
To further substantiate the mechanistic association be-
tween HIF-1α stabilized by Co/Ni ions and lung inflam-
mation (Table 3), we next assessed in vitro the HIF-1α
response to LIB particles in BEAS-2B cells. This simplified
model allows isolating the HIF-1α response from the mul-
tiple inflammatory components present in the lung.
BEAS-2B cells were exposed to increasing doses of LIB
particles (30 to 1000 μg/ml), the lowest concentration
matching in vivo doses (See Additional file 1: Figure S4).
Higher concentrations were also tested because, in vivo,
lung cells were exposed to Co ions released during 2
months while, in vitro, cells were exposed only during 24
h. NMC8:1:1 and 6:2:2 were cytotoxic at 30 μg/ml and
LCO at 1000 μg/ml. A very slight cytotoxicity appeared at
1000 μg/ml for the other particles (Fig. 6a). At 30 and
100 μg/ml, HIF-1α stabilization was stronger for LCO and
NMC1:1:1. At 1000 μg/ml, all LIB particles induced a
strong HIF-1α stabilization (Fig. 6b). Co3O4, which did
not induce high lung inflammation in vivo compared to
the LIB particles (Fig. 2), induced a weaker HIF-1α
stabilization than LIB particles in vitro. Using the results
of in vivo experiments (Fig. 2), bivariate analyses revealed
a positive correlation between the in vivo inflammatory re-
sponse (BAL inflammatory cell infiltration) and in vitro
HIF-1α stabilization in BEAS-2B cells. Analyses were per-
formed on HIF-1α stabilization at all doses tested in vitro
(30, 100, 300 or 1000 μg particles/ml). All correlations
were significant, the relation at 30 μg particles/ml which
best matches the in vivo doses is illustrated here (Fig. 7).
These results confirm that the simple presence and release
of Co/Ni from LIB particles and their ability to stabilize
Table 1 Particle characterization
LCO NCA NMC 1:1:1a NMC 6:2:2 NMC 8:1:1
Density (g/cm3)b 2.37 2.95 1.93 2.84 1.93
Diameter (μm)c 6.47 6.13 5.16 11.34 7.53
FPF (% of total weight)d 7.21 2.01 1.64 1.84 2.15
Li (%)e 7.1 3.28 7.24 7.16 7.14
Co (%)e 60.2 27.86 20.22 12.12 6.03
Ni (%)e / 27.75 20.22 36.35 48.28
Mn (%)e / / 18.92 11.34 5.65
Al (%)e / 25.98 / / /
O (%)e 32.7 15.13 33.40 33.03 32.9
aThe three digits reflect the Ni:Mn:Co mass ratio in the particles
bMeasured by powder tap density
cMedian hydrodynamic diameter determined by centrifugal liquid sedimentation (CLS) (weight-based distribution)
dFine particle fraction (FPF, ≤ 5 μm) determined by Andersen cascade impaction
eas reported by the producers
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HIF-1α determine the in vivo inflammation, independ-
ently of all other possible components.
Compared to % Co +Ni content or bioaccessibility,
HIF-1α stabilization in vitro integrates a number of fac-
tors such as intracellular distribution of Co/Ni ions, and
measures the bioactivity of these elements, offering an
additional option to predict the toxic potential of (new)
LIB particles, hence reducing in vivo testing. The measure-
ment of HIF-1α stabilization in vitro in BEAS-2B cells, the
Co/Ni content of LIB particles and their bioaccessibility
are, therefore, useful predictors of the lung inflammatory
potential of LIB particles.
Discussion
We observed here that LIB particles containing Co and/
or Ni induce lung inflammation and even fibrotic re-
sponses in mice. We show that Co and/or Ni contents
and bioaccessibility, as well their capacity to stabilize
HIF-1α, are determinants of lung inflammation. We also
demonstrated that HIF-1α in lung cells mediates LCO-
Fig. 2 Lung inflammatory and fibrotic responses induced by LIB particles. C57BL/6Jrj mice were treated with an oro-pharyngeal aspiration of NaCl
(control), 0.5, 1 or 2 mg LCO, NMC 1:1:1, NMC 6:2:2, NMC 8:1:1, NCA or Co3O4. Mortality is shown in survival curves (a). Surviving mice were
euthanized after 2 months. Inflammatory cell infiltration (b) was measured in BALF. Fibrotic response (c) severity was scored according to Hübner
et al. (2008). HIF-1α (d) was measured in lung homogenates. Number of surviving mice is indicated for each condition above the columns (b).
*P < 0.05, **P < 0.01 and ***P < 0.001 relative to NaCl-treated mice (one-way ANOVA followed by a Dunnett’s multiple comparison or t test, N = 1,
n = 4–6 (treated mice), means ± SEM)
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Fig. 3 Bioaccessibility of Co and Ni from LIB particles. LIB particles and Co3O4 were incubated in artificial fluids mimicking the extracellular (pH
7.3) (a, c) or the phagolysosomal (pH 4.2) (b, d) compartment. Particles were incubated at 37 °C under gentle agitation and released Co (a, b) and
Ni concentrations (c, d) were determined by ICP-MS in the SN after centrifugation of an aliquot of the suspensions after 3, 24 h, 7, 14 and 30 days
Table 2 Correlation between mortality recorded at day 18 and
Ni/Co content or Ni/Co released by the particles
Correlation coefficient p-value
Co content −0.064 0.801
Ni content 0.760 0.0002
Bioaccessible Co −0.079 0.755
Bioaccessible Ni 0.719 0.001
Ni + Co content 0.163 0.517
Bioaccessible Ni + Co 0.176 0.484
Mice were treated with 0.5, 1 or 2 mg LIB particles (see Fig. 2). Bivariate
analysis (Spearman Rho) between the mortality % at day 18, and the particle
Ni and/or Co content (μg) or the amount of Ni and/or Co ions (μg) released.
Co and/or Ni contents were calculated from the administered doses and from
the Co and/or Ni % of the particles. Bioaccessible Co and/or Ni represent the
amount of bioaccessible ions, calculated from the Co/Ni contained in the
administered doses and the % released at pH 4.2 at day 14 (mortality was
recorded between day 6 and 18). Significant relationships are identified in bold
Table 3 Tracing the determinants of lung inflammation
induced by LIB particles after 2 months
Correlation coefficient p-value
LDH 0.183 0.195
HIF-1α 0.311 0.025
Co content 0.245 0.080
Ni content 0.065 0.270
Bioaccessible Co −0.020 0.886
Bioaccessible Ni 0.035 0.806
Ni + Co content 0.480 0.0003
Bioaccessible Ni + Co 0.445 0.0004
Bivariate analysis (Pearson correlation) between the inflammatory cell
recruitment, selected as marker of lung inflammation and HIF-1α, LDH activity,
the particle Ni and/or Co content (μg) or the amount of Ni and/or Co ions (μg)
released. Inflammatory cell recruitment was assessed in the BAL, HIF-1α (μg/
ml) was measured in lung homogenates, LDH activity (iU/l) in BALF. Co and/or
Ni contents were calculated from the administered doses and from the Co
and/or Ni % of the particles. Bioaccessible Co and/or Ni represent the amount
of bioaccessible ions, calculated from the Co/Ni contained in the administered
doses and the % released at pH 4.2 at day 30. Significant relationships are
identified in bold
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induced inflammation and is an upstream signal of the re-
sponses. In addition to the well-known implication of HIF
in the development of cancer, invasion and metastasis,
HIF-1α also plays many roles in inflammation, induces the
secretion of inflammatory mediators and promotes myofi-
broblast differentiation as well as epithelial-mesenchymal
transition via the TGF-β pathway [6, 20–22].
Pulmonary diseases including cancer, asthma and fibros-
ing alveolitis have previously been reported in workers ex-
posed to cobalt [13, 14]. Cobalt compounds can induce
cytotoxicity, apoptosis, inflammatory responses and geno-
toxicity in vitro [23]. Some of the effects of cobalt are re-
lated to its high affinity for sulfhydryl groups leading to
enzyme inactivation, antagonism for Ca2+ channel cell
signalling, production of reactive oxygen species leading
to oxidative stress, and finally to its ability to stabilize
HIF-1α [23, 24]. LCO containing the highest % of Co
among the range of particles tested, and Co being sus-
pected to be the element responsible for the high toxicity
of LCO, we hypothesized that others particles (with lower
Co content) would induce lower lung effects than LCO.
However, acute toxicity was observed early after exposure.
In addition to cobalt, some LIB particles contain nickel,
which appears as the element responsible for the observed
mortality. Previous studies have shown that acute inhal-
ation exposure to Ni induced lethal injury characterized
Fig. 4 HIF-1α drives lung inflammation induced by LCO. C57BL/6Jrj mice were treated with an oro-pharyngeal aspiration of NaCl (control), 0.5 or
2 mg LCO or crystalline silica (Sil). Mice received i.p. injections of 0.5 mg/kg bw/d chetomin or vehicle (saline solution with 10% DMSO) at day − 1,
1 and 2 and were enthanized at day 3. Alveolar inflammatory cell infiltration and neutrophils were assessed in the BAL (a, b). IL-1β (c) and IL-6 (d)
were measured in BALF; Lung sections of mice exposed to 2 mg particles were stained with HE (magnification 10x and 200x) (e). *P < 0.05, **P <
0.01 and ***P < 0.001 (t-test between chetomin - and +mice for each condition, N = 1, n = 5, means ± SEM)
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by inflammatory cell infiltration, haemorrhage and de-
struction of alveolar epithelial cells [25, 26]. Chronic
exposure to Ni can lead to asthma, inflammation, pul-
monary fibrosis, kidney diseases and cancer [10, 15].
Like Co, Ni is able to stabilize HIF-1α by blocking the
iron-binding group of the prolyl hydroxylase [10]. As
inhibition of prolyl hydroxylase activates nuclear factor
(NF)-κB [27], Co and Ni ions can thus both participate
to the activation of NF-κB, leading to inflammation, as
previously suggested [28]. The Co and Ni contents of LIB
particles and their bioaccessibility are, indeed, correlated
to the in vivo lung inflammation in the present study.
HIF-1α was also correlated to the in vivo lung inflam-
mation induced by LIB particles. Moreover, inhibition of
HIF-1α led to a reduction of lung inflammation induced
by LCO particles, indicating the key pathogenic role of
this transcription factor. HIF-1α can promote NF-κB ac-
tivity in macrophages, neutrophils and non-immune
cells, resulting in the transcription of target genes of in-
flammation such as pro-inflammatory cytokines (tumor
necrosis factor (TNF)-α, IL-6, IL-1, IL-12) [29, 30]. To
test the implication of HIF-1α in LCO lung inflamma-
tion, we first used chetomin which binds to the Zn2+-
binding cysteine/histidine rich 1 (CH1) domain of p300,
leading to a reduction of the interaction between HIF-1α
and P300 [16] and reduces the expression of HIF-1α tar-
get genes [16, 31]. Chetomin drastically reduced LCO
lung inflammation. These observations were confirmed
by the use of PX-478 which inhibits HIF-1α transcrip-
tion and translation by another mechanism than cheto-
min [16, 18]. Thus, we showed here, for the first time,
the implication of HIF-1α in lung inflammation induced
by particles containing Co and/or Ni. We conclude that
inflammation induced by LCO is dependent on HIF-1α.
In addition, the HIF-1α response to LCO was main-
tained in the absence of inflammation in IL-1β KO mice.
We can thus conclude that HIF-1α is an upstream signal
of the lung inflammatory responses to LIB particles con-
taining Co. These results are consistent with Rius et al.
[32] who showed that if NF-κB can regulate HIF-1α
Fig. 5 HIF-1α stabilization after LCO acts upstream of inflammation. C57BL/6Jrj or IL-1β KO mice were treated with an oro-pharyngeal aspiration
of NaCl (control), 2 mg LCO or crystalline silica (Sil). Mice were euthanized after 3 days. Alveolar inflammatory cell infiltration (a) and neutrophils
(b) were assessed in the BAL, and IL-6 (c) was measured in BALF; HIF-1α in lung homogenates (d). *P < 0.05, **P < 0.01 and ***P < 0.001 (t-test
between WT and IL-1β KO mice for each condition, N = 1, n = 5, means ± SEM)
Fig. 6 Cytotoxicity and HIF-1α stabilization induced by LIB particles in BEAS-2B cells. BEAS-2B cells were exposed to NaCl (control), 30, 100, 300 or
1000 μg/ml of LCO, NCA, NMC 1:1:1, NMC 6:2:2, NMC 8:1:1 or Co3O4. Cytotoxicity was assessed after 24 h (a) by the WST-1 assay. HIF-1α (b)
protein contents were measured in cell lysates. (N = 2, n = 4, means ± SEM)
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transcription in activated macrophages, NF-κB activation
alone is, however, not sufficient to stabilize HIF-1α, indi-
cating that both transcriptional and post-transcriptional
(like Co and Ni ions) regulators are implicated in HIF-
1α production/stabilization.
The Co and Ni content of LIB particles and their bio-
accessibility at pH 4.2 represent thus good indicators of
the toxic potential of LIB particles. To refine the predict-
ive information, we can also measure HIF-1α protein
stabilization in BEAS-2B cells exposed to LIB particles.
A study comparing 10 commonly used cell lines con-
cluded that BEAS-2B cells are useful for toxicological
studies because they exhibit the highest homology in
gene expression pattern with human primary cells and
the lowest number of dysregulated genes compared with
non tumoral lung tissues [33]. Moreover, BEAS-2B have
been previously used to study the toxicity of cobalt com-
pounds [12, 34]. The BEAS-2B cell line is thus an appro-
priate model to evaluate the lung inflammatory potential
of LIB particles by measuring the stabilization of the key
mediator HIF-1α.
A large variety of materials are in use in or under con-
sideration for the development of LIB materials. While
micro-sized particles, as tested in the present study, are
currently used in most commercialized batteries, nano-
sized materials are in intense development to improve
technical performances [35]. The nanosize is a plausible
source of additional concern as it can result in more
severe hazardous properties and increased particle ex-
posure via inhalation. Thus, toxicological evaluation of
existing and newly developed LIB particles appears as a
priority. We identified the Ni and Co content of LIB
particles and their bioaccessibility, as well as HIF-1α as
key determinants of the lung inflammatory responses to
LIB particles. Evaluating HIF-1α levels in BEAS-2B cells
exposed to LIB particles is a predictor of their inflamma-
tory potential.
Conclusions
We report the implication of HIF-1α induced by Ni and
Co ions in lung inflammatory responses induced by LIB
particles. HIF-1α is the upstream signal of the inflamma-
tory responses induced by these LIB particles, participat-
ing to the secretion of IL-1β. Documenting the amount
of Co and Ni in LIB particles, their bioaccessibility as
well as HIF-1α stabilization in BEAS-2B cells, predict
the lung toxicity of LIB particles.
Methods
Particles
LCO (LiCoO2) was obtained from MTI Corporation
(Richmond, USA), NCA (LiNiCoAlO2), NMC 1:1:1
(LiNi0.33Co0.33Mn0.33O2), NMC 6:2:2 (LiNi0.6Co0.2Mn0.2O2)
and NMC 8:1:1 (LiNi0.8Co0.1Mn0.1O2) from Umicore,
cobalt oxide (Co3O4, size < 10 μm, 221,643) from Sigma-Al-
drich (Missouri, USA) and micrometric crystalline silica
particles (Min-U-Sil 5, d50 1.6 μm) from US Silica (Berkley
Springs, USA). Before all experiments, particles were heated
2 h at 200 °C to inactivate any possible endotoxin or other
microbial contaminants.
Particle solubilization
To assess the bioaccessibility of elements contained in
LIB particles, 10 mg particles were incubated in 10ml
artificial fluids mimicking the extracellular (pH 7.3) or
the phagolysosomal (pH 4.2) compartments as previously
described [36]. Particles were incubated during 30 days
at 37 °C under gentle agitation. One ml aliquots were
collected after 3, 24 h, 7, 14 and 30 days and centrifuged
(20,000 g, 10 min). Element concentrations were deter-
mined in the SN by ICP-MS.
Particle characterization
The density of LIB particles was assessed by tap density
measurement and their aerodynamic size distribution in
an Andersen cascade impactor (1 ACFM Eight Stage
Non-Viable Cascade Impactor, Graseby Andersen, Atlanta,
USA) as previously described [5]. The particle size dis-
tribution, based on the hydrodynamic diameter was
also assessed by CLS on a DC24000 system (CPS in-
struments Inc., Stuart, Florida, USA), equipped with a
405-nm wavelength laser detector, with PVC standard
(nominal particle size = 719 nm). Sizes are expressed in
terms of hydrodynamic diameter assuming all particles
are spherical. Each measurement was done by injecting
0.1 ml of a 1 mg particle/mL suspension in NaCl 0.9%.
Fig. 7 Correlation between inflammation induced by LIB particles in
vivo and HIF-1α stabilization in vitro. Scatter graph and bivariate
analysis demonstrate a positive correlation between the inflammatory
cell recruitment level induced by LIB particles after 2months in mice
(see Fig. 2) and the stabilization of HIF-1α (pg/ml) in BEAS-2B at the
concentration of 30 μg LIB particle/ml (see Fig. 6). (y = 0.006671 x +
4.06; p < 0.0001; r = 0.532)
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Animals and treatments
Female C57BL/6JRj mice were purchased from Janvier
Labs (St Bertevin, France). Interleukin (IL)-1β deficient
(knock-out, −/−) mice (C57BL/6 J background) were ob-
tained from the Transgenose Institute (Orleans, France).
Eight-week-old animals were kept with sterile rodent
feed and acidified water, and housed in positive-pressure
air-conditioned units (25 °C, 50% relative humidity) on a
12 h light/dark cycle. Particles were suspended in sterile
0.9% saline. Mice were randomly allocated to experimen-
tal groups. After anaesthesia with a mix of Nimatek, 1
mg/mouse (Eurovet, Bladel, Nederland) and Rompun,
0.2 mg/mouse (Bayer, Kiel, Germany) given intraperito-
neally, a 50 μl suspension of particles or NaCl (controls)
was directly administered by oro-pharyngeal aspiration.
Single dose administration of particles is a convenient
alternative to inhalation exposure for initial hazard iden-
tification [37, 38] and induces qualitatively similar lung
responses as inhalation exposure [39, 40]. Crystalline
silica particles were used as reference material. Inflam-
matory and fibrotic responses are recorded in mice with
a dose of 2 mg crystalline silica particles administered
via oro-pharyngeal aspiration [41–44]. LIB particles were
tested at doses of 0.1, 0.5 or 2 mg to allow benchmarking
of their respiratory toxicity relative to crystalline silica
particles.
Chetomin (Sigma-Aldrich) or vehicle (saline solution
with 10% dimethylsulfoxide (DMSO, Sigma-Aldrich))
was injected intraperitoneally at 0.5 mg/kg bw/d for the
3 days experiment, one day before administration of the
particles and during the 2 following days, or 3 times per
week for long term experiments. PX-478 (S-2-amino-3-
[4′-N,N,-bis (2-chloroethyl)amino] phenyl propionic
acid N-oxide dihydrochloride, Cayman Chemicals, Mich-
igan, USA) or vehicle (saline solution with 10% DMSO)
was injected intraperitoneally at 20 mg/kg bw/d, one day
before administration of the particles and during the
2 following days. Mice were euthanized 3 days or 2
months after particle administration with an intraperi-
toneal injection of 12 mg sodium pentobarbital (Certa,
Braine-l’Alleud, Belgium).
Broncho-alveolar lavage and lung sampling
Broncho-alveolar lavage (BAL) was performed by cannu-
lating the trachea and infusing the lungs with 1 ml NaCl
0.9%. Whole lungs were then perfused with NaCl 0.9%
and excised. Left lobes were placed in 3.65% paraformal-
dehyde (Sigma-Aldrich, St Louis, Missouri, USA) in
phosphate buffered saline (PBS) for later histological
analysis, and remaining lobes in liquid nitrogen or lysis
buffer for homogenization. Lungs were homogenized on
ice with an Ultra-Turrax T25 (Janke and Kunkel, Brussels,
Belgium) and stored at − 80 °C. BAL were centrifuged
10 min at 4 °C (240 g). Cell-free supernatant (BALF)
was used for biochemical measurements. After resuspension
of the pellet in PBS, total BAL cells were counted in Turch
(crystal violet 1%, acetic acid 3%) and cytocentrifuged for dif-
ferentiation by light microscopy after Diff-Quick staining
(200 cells counted, Polysciences, Warrington, UK). Lactate
dehydrogenase (LDH) activity was assayed on BALF as de-
scribed previously [42].
Quantification of IL-1β, IL-6 and HIF-1α
IL-1β and IL-6 were quantified by enzyme-linked im-
munosorbent assay (ELISA) (Limit of detection (LOD):
7.8 pg/ml, DuoSet ELISA, R&D Systems, Minneapolis,
USA) in BALF following manufacturer’s instructions.
HIF-1α (LOD: 31.25 pg/ml, DuoSet ELISA, R&D Sys-
tems) was assessed in SN of lung homogenates (centri-
fuged 10min at 240 g, 4 °C) or in the cell culture after
lysis following manufacturer’s instructions.
Histology and fibrosis scoring
Paraffin-embedded lung sections were stained with HE
(lung structure staining) or Sirius Red (type I and III
collagen staining). The sections were scanned (Leica
SCN400, Brussels, Belgium) and examined with Tissue
Image Analysis 2.0 (Leica Biosystems). Fibrotic responses
was quantified using a modified Ashcroft scale (grade 0
to 8) standardized for fibrosis evaluation in small ani-
mals (clear fibrotic changes are observed from the grade
2) [45]. Analyses were performed under blind conditions
by the same investigator.
Cell culture and in vitro exposure
BEAS-2B cells (human bronchial epithelial cell line,
ATCC, Virginia, USA) were cultured at 37 °C in complete
medium, i.e. LHC-9 medium (Gibco, Paisley, UK) supple-
mented with 1% antibiotic-antimycotic (Gibco) on coated
surfaces. Culture flasks and plates were precoated with a
mixture (60 μl/cm2) of 0.01mg/mL fibronectin (Fibronec-
tin from human plasma 0.1%, Sigma), 0.03mg/mL bovine
collagen type I (collagen coating solution 50 μg/ml, Sigma)
and 0.01mg/mL bovine serum albumin (7.5% in PBS,
Sigma) at least 2 h at 37 °C and then washed 1 x with PBS
(Gibco, Paisley, UK) before cell seeding. Cells were subcul-
tured and exposed before reaching confluence. Before ex-
posure, BEAS-2B were plated in 96-well plates or 48-well
plates (30 000 cells/cm2 culture well surface area) in
complete medium. After 24 h, cells were exposed to the
particles during 24 h in culture medium (150 μl/well for
48-well plates (0.95 cm2/w) and 100 μl/well for 96-well
plates (0.32 cm2/w)). Given the similar size and density of
the tested particles (Table 1), differential sedimentation
and cellular doses are unlikely to confound the results.
All tested particles directly sedimented in the cell cul-
ture well.
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Supernatants (SN) of cell culture were collected and
stored at − 80 °C for later analysis. Cells were then
washed once with LHC basal medium and viability was
evaluated by using the water soluble tetrazolium salts
(WST-1) assay (Roche, Mannheim, Germany, 5%) fol-
lowing manufacturer’s instructions (96-well plates). Cells
cultured in 48-well plates were washed and lysed for
HIF-1α dosage following manufacturer’s instructions.
Statistics
Graphs and statistical analyses were performed with
GraphPad Prism 5.0 and/or Microsoft excel 2013. Bivari-
ate analyses were performed with IBM SPSS statistics 25.
All results are expressed as means ± standard errors on
the mean (SEM). Differences between control and treated
groups were evaluated by one-way analysis of variance
(ANOVA), followed by a Dunnett’s multiple comparison,
or by a t test. Statistical significance was considered
at P < 0.05.
Additional file
Additional file 1: Figure S1. Particle size distributions. LCO (a, d), NCA
(b, e), NMC 1:1:1 (c, f), NMC 6:2:2 (g, i) and NMC 8:1:1 (h, j) size distributions
(weight based distributions (a-c, g-h) and number based distributions (d-f, i-j))
assessed by centrifugal liquid sedimentation. Figure S2. Lung sections of
mice 2months after treatment with LIB particles. C57BL/6Jrj mice were treated
with an oro-pharyngeal aspiration of NaCl (control), 0.5, 1 or 2mg LCO, NMC
1:1:1, NMC 6:2:2, NMC 8:1:1, NCA or Co3O4. Lung sections were stained with
Sirius red (magnification 200x). Figure S3. HIF-1α drives lung inflammation
induced by LCO. C57BL/6Jrj mice were treated with an oro-pharyngeal
aspiration of NaCl (control) or 2mg LCO. Mice were treated with i.p. injections
of 20mg/kg bw/d PX-478 or with the vehicle (saline solution with 10%
DMSO) at day − 1, 1 and 2. Mice were euthanized after 3 days. Inflammatory
cell infiltration was assessed in the BAL (a). Lung sections were stained with
HE (magnification 10x) (b). *P < 0.05, **P < 0.01 and ***P < 0.001 (t-test
between PX-478 - and +mice for each condition, N = 1, n = 5, means ± SEM).
Figure S4. Comparison of in vivo and in vitro doses. (PDF 1102 kb)
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